.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Covington
Chubb
Citi
Moodys
McKesson
QuintilesIMS
Merck
Cantor Fitzgerald
Cerilliant

Generated: December 17, 2017

DrugPatentWatch Database Preview

Triamcinolone diacetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for triamcinolone diacetate and what is the scope of triamcinolone diacetate patent protection?

Triamcinolone diacetate
is the generic ingredient in three branded drugs marketed by Sandoz Inc, Akorn, Watson Labs, Astellas, and Delcor Asset Corp, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty-one drug master file entries for triamcinolone diacetate.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson LabsTRIAMCINOLONE DIACETATEtriamcinolone diacetateINJECTABLE;INJECTION085529-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
AstellasARISTOCORTtriamcinolone diacetateSYRUP;ORAL011960-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson LabsTRIAMCINOLONE DIACETATEtriamcinolone diacetateINJECTABLE;INJECTION084072-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz IncARISTOCORTtriamcinolone diacetateINJECTABLE;INJECTION012802-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
AkornTRIAMCINOLONE DIACETATEtriamcinolone diacetateINJECTABLE;INJECTION086394-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz IncARISTOCORTtriamcinolone diacetateINJECTABLE;INJECTION011685-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
AkornTRIAMCINOLONE DIACETATEtriamcinolone diacetateINJECTABLE;INJECTION085122-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset CorpKENACORTtriamcinolone diacetateSYRUP;ORAL012515-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
McKinsey
Argus Health
US Army
US Department of Justice
Dow
Accenture
Teva
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot